Can Sulindac Be Used for Knee Pain?
Yes, sulindac can be used for knee pain, specifically when the pain is due to osteoarthritis, as it is FDA-approved for this indication and supported by clinical guidelines recommending oral NSAIDs for knee osteoarthritis. 1
FDA-Approved Indication
Sulindac is FDA-approved for osteoarthritis, which commonly affects the knee joint 1. In controlled clinical trials, sulindac 200-400 mg daily demonstrated comparable effectiveness to aspirin 2400-4800 mg daily for osteoarthritis of the hip and knee, with improvements in pain (including weight-bearing pain, pain on active/passive motion, and night pain), joint mobility, swelling, tenderness, and functional activities 1.
Guideline Support for NSAIDs in Knee Pain
The 2012 American College of Rheumatology guidelines conditionally recommend oral NSAIDs as one of the initial pharmacologic options for knee osteoarthritis 2. The treatment algorithm suggests:
- First-line options: Acetaminophen, oral NSAIDs (including sulindac), topical NSAIDs, tramadol, or intraarticular corticosteroid injections
- If acetaminophen fails: The guidelines strongly recommend using oral or topical NSAIDs or intraarticular corticosteroid injections 2
The 2008 NICE guidelines similarly recommend considering oral NSAIDs for knee osteoarthritis when paracetamol (acetaminophen) provides insufficient relief 3.
Specific Considerations for Sulindac Use
Dosing: For osteoarthritis, sulindac is typically dosed at 150-200 mg twice daily (300-400 mg/day total) 1
Age considerations: For patients ≥75 years, guidelines strongly recommend topical rather than oral NSAIDs 2. If oral NSAIDs are necessary in elderly patients, use the lowest effective dose with appropriate monitoring 4.
GI protection: In patients with GI risk factors (age ≥60, history of peptic ulcer disease, GI bleeding, concurrent corticosteroids/anticoagulants), combine sulindac with a proton pump inhibitor or consider alternative agents 2, 4. Note that sulindac has been specifically mentioned as having more potential for hepatic complications compared to other NSAIDs 4.
Renal monitoring: Since sulindac is eliminated primarily by the kidneys, patients with significantly impaired renal function require close monitoring and lower dosages 1.
Clinical Evidence
Comparative studies show sulindac is effective for knee osteoarthritis pain. In elderly patients with osteoarthritis of the hip/knee, sulindac 400 mg/day showed significant improvements in weight-bearing pain, pain on passive movement, and disease activity 5. Another study found sulindac 400 mg/day comparable to naproxen 500 mg/day with good tolerability 6.
Common Pitfalls to Avoid
- Do not use sulindac as monotherapy in patients with contraindications to NSAIDs (active GI bleeding, severe renal impairment, heart failure)
- Do not exceed recommended doses or use for prolonged periods without monitoring
- Do not forget gastroprotection in high-risk patients
- Do not use in patients ≥75 years without considering topical NSAIDs first 2